摘要
背景:在中国,结核病(TB)是威胁生命的疾病,并且新的治疗药物和治疗方案治疗结核病是迫切需要的。 目的:在这项研究中,DNA疫苗表达结核分枝杆菌(MTB)构建了 Rv1419抗原,并对其免疫原性和治疗效果进行了评价。 方法:正常小鼠和结核病模型小鼠肌肉分别每隔两个星期注射免疫和生理盐水三次,质粒载体 pVAX1, M. vaccae vaccine, pVAX1- ag85a (rv3804c) DNA 或者 pVAX1-rv1419 DNA。 结果:在三周最后一次免疫后,流式细胞仪检测表明,与生理盐水组和向量组(P<0.05)相比,较高比例的CD4 + T细胞表达IFN-γ(Th1)响应rv1419蛋白在血液从pVAX1 - rv1419 DNA组,表明主导Th1型免疫应答。相比生理盐水对照组,活菌量肺和脾脏均低于0.41 log10的pVAX1 - rv1419 DNA组。此外,DNA疫苗组肺部的病理变化较少。这些结果表明,pVAX1 - rv1419 DNA可为结核病的治疗是有效的,显著增加Th1型细胞免疫反应,抑制结核杆菌的生长 结论:因此pVAX1 - rv1419 DNA是一个可行结核病治疗组合DNA疫苗中的包涵体组成成分。
关键词: DNA疫苗,pVAX1-rv1419 DNA,免疫治疗,结核分枝杆菌,Rv1419 protein,免疫。
Current Gene Therapy
Title:Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis
Volume: 16 Issue: 4
Author(s): Yan Liang, Xiaoyan Zhang, Li Xiao, Xuejuan Bai, Xiaomei Wang, Yourong Yang, Junxian Zhang, Jinying Song, Yinping Liu and Ning Li, Xueqiong Wu
Affiliation:
关键词: DNA疫苗,pVAX1-rv1419 DNA,免疫治疗,结核分枝杆菌,Rv1419 protein,免疫。
摘要: Background: Tuberculosis (TB) is threatening disease in China and new therapeutic agents and regimens to treat TB are urgently needed.
Objective: In this study, a DNA vaccine expressing Mycobacterium tuberculosis (MTB) Rv1419 antigen was constructed and its immunogenicity and therapeutic effects were evaluated. Method: Normal mice and TB model mice were immunized intramuscularly three times at two-week intervals with saline, plasmid vector pVAX1, M. vaccae vaccine, pVAX1- ag85a (rv3804c) DNA or pVAX1-rv1419 DNA, respectively. Results: At three weeks after the last immunization, flow cytometry showed a higher proportion of CD4+ T cells expressing IFN-γ (Th1) in response to Rv1419 protein in blood from the pVAX1- rv1419 DNA group compared with the saline and vector groups (P<0.05), suggesting a predominant Th1 immune response. Live bacterial loads in lungs and spleens were lower by 0.41 log10 in the pVAX1- rv1419 DNA group than in the saline controls. In addition, pathological changes in the lungs of the DNA vaccinated groups were less. These results suggest that pVAX1- rv1419 DNA could be effective for the treatment of TB, significantly increasing the Th1-type cellular immune response, and inhibiting the growth of MTB. Conclusion: Therefore pVAX1- rv1419 DNA is a candidate for inclusion in a therapeutic combination DNA vaccine against TB.Export Options
About this article
Cite this article as:
Yan Liang, Xiaoyan Zhang, Li Xiao, Xuejuan Bai, Xiaomei Wang, Yourong Yang, Junxian Zhang, Jinying Song, Yinping Liu and Ning Li, Xueqiong Wu , Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis, Current Gene Therapy 2016; 16 (4) . https://dx.doi.org/10.2174/1566523216666161102170123
DOI https://dx.doi.org/10.2174/1566523216666161102170123 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nonprofit Pharma: Solutions to What Ails the Industry
Current Medicinal Chemistry Effect of Vitamin D Supplementation in Type 2 Diabetes Patients with Tuberculosis: A Systematic Review
Current Diabetes Reviews Multiscale Modelling of Relationships between Protein Classes and Drug Behavior Across all Diseases Using the CANDO Platform
Mini-Reviews in Medicinal Chemistry Design, Synthesis and Computational Studies of New Benzothiazole Substituted Quinazolines as Potential Antimicrobial Agents
Letters in Drug Design & Discovery Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives
Medicinal Chemistry QSAR as a Random Event: Selecting of the Molecular Structure for Potential Anti-tuberculosis Agents
Anti-Infective Agents Isoniazid: an Update on the Multiple Mechanisms for a Singular Action
Current Medicinal Chemistry Vitamin D in COPD - A Pleiotropic Micronutrient in a Multisystem Disease
Current Respiratory Medicine Reviews Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Expression, Purification, Crystallization and Preliminary X-Ray Crystallographic Analysis of the Resuscitation Promoting Factor Interacting Protein RipA from M. tuberculosis
Protein & Peptide Letters The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms
Mini-Reviews in Medicinal Chemistry Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Current Pharmaceutical Design Expression, Purification and Characterisation of Haemophilus influenzae 3-Isopropylmalate Dehydrogenase (LeuB)
Protein & Peptide Letters Management of Spondyloarthropathy in Asian Countries
Current Rheumatology Reviews An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design Thermal Stability of Thermoanaerobacter tengcongensis Ribosome Recycling Factor
Protein & Peptide Letters Brucellosis Serostatus Among Pregnant Women with Spontaneous Abortion and Stillbirth
Current Women`s Health Reviews Targeted Drug Delivery to Macrophages in Parasitic Infections
Current Drug Delivery